Immune cells and their inflammatory mediators modify β cells and cause checkpoint inhibitor–induced diabetes is a research paper published in JCI Insight (2022). On theSindex it has a DataRank of 0. It has been cited 51 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA227473,T32DK007058,K12 CA215110
National Institutes of Health
Grant: P30DK116577
Juvenile Diabetes Research Foundation International
Grant: APF-2019-753-A-N
Parker Foundation
Grant: N/A
National Institutes of Health
Grant: 5T32DK007058-46
Diabetes Mellitus and Disorders of Metabolism
National Institutes of Health
Grant: 3R01CA227473-02S1
(8) Mechanisms of autoimmune endocrine diseases in patients receiving checkpoint inhibitors
National Institutes of Health
Grant: 1R43DK116577-01
Novel diagnostics for autoimmunity from checkpoint inhibitor immune therapy
National Institutes of Health
Grant: 1K12CA215110-01A1
The Yale Cancer Center Calabresi Immuno-Oncology Training Program (IOTP)
NCI NIH HHS
Grant: R01 CA227473
NCATS NIH HHS
Grant: UL1 TR001863
NCI NIH HHS
Grant: K12 CA215110
NIDDK NIH HHS
Grant: P30 DK045735
NIDDK NIH HHS
Grant: R43 DK116577
NIDDK NIH HHS
Grant: T32 DK007058
NIDDK NIH HHS
Grant: K08 DK122130
FWCI
4.11
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals